Inhibition of Ca(2+)-dependent catecholamine release by myosin light chain kinase inhibitor, wortmannin, in adrenal chromaffin cells

Biochem Biophys Res Commun. 1992 Jun 30;185(3):1016-21. doi: 10.1016/0006-291x(92)91728-9.

Abstract

To elucidate the possible involvement of myosin light chain kinase (MLCK) in the mechanism of exocytosis, we studied effects of MLCK inhibitor, wortmannin, on the secretory function of bovine adrenal chromaffin cells. Preincubation of chromaffin cells with wortmannin inhibited both acetylcholine- and high K(+)-evoked catecholamine (CA) release. The IC50 for high K(+)-evoked CA release was 1 microM. When the cells were permeabilized with digitonin after wortmannin preincubation, Ca(2+)-dependent exocytosis was inhibited in a dose-dependent manner (IC50, 1 microM). These findings suggest the implication of MLCK in the Ca(2+)-triggered process in the machinery of exocytosis.

MeSH terms

  • Acetylcholine / pharmacology
  • Adrenal Medulla / drug effects
  • Adrenal Medulla / metabolism*
  • Androstadienes / pharmacology*
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Calcium / pharmacology*
  • Catecholamines / pharmacology*
  • Cattle
  • Cells, Cultured
  • Exocytosis / drug effects
  • Kinetics
  • Myosin-Light-Chain Kinase / antagonists & inhibitors*
  • Potassium / pharmacology
  • Wortmannin

Substances

  • Androstadienes
  • Anti-Inflammatory Agents
  • Catecholamines
  • Myosin-Light-Chain Kinase
  • Acetylcholine
  • Potassium
  • Calcium
  • Wortmannin